This article was reviewed by Katelyn Hagerty, FNP. The 8 Strongest Acne Medications Step into your local drugstore and you’ll come across countless cleansers, serums, lotions ...
Oral treatment with the novel fatty acid synthase inhibitor denifanstat induced significant improvements in ...
Studies show that azelaic acid also regulates skin cell turnover. This is important for two reasons. It keeps pores clear of debris and tackles what Dr. Mahto calls hyperkeratinization—a key ...
If you told 20-year-old me that I was going to become a beauty editor and talk to people about skincare, I would’ve laughed in your face. Looking back, the thing that changed my life both physically ...
Now, there’s a new way to take the medication. Meet the “Hollywood Dose,” aka microdosing Accutane.
Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...
"Mild instances of acne can generally improve through home remedies such as gentle cleansing, applying non-comedogenic ...
Research suggests that those with less omega-3 fatty acids in their diet tend to suffer more from this skin condition.
Detailed price information for Sagimet Biosciences Inc Series A (SGMT-Q) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results